GSK, FDA warn doctors against dissolving Relenza

10/11/2009 | MarketWatch

The FDA and GlaxoSmithKline warned doctors that antiviral drug Relenza should not be administered with a nebulizer or ventilator, or "reconstituted in any liquid formulation." Relenza, which is sometimes dissolved for patients who cannot take oral medications, reportedly caused the death of an influenza patient who received the drug through a mechanical ventilator.

View Full Article in:

MarketWatch